NGUYEN, Thanh N, Muhammad M QURESHI, Piers KLEIN, Hiroshi YAMAGAMI, Mohamad ABDALKADER, Robert MIKULÍK, Anvitha SATHYA, Ossama Yassin MANSOUR, Anna CZLONKOWSKA, Hannah LO, Thalia S FIELD, Andreas CHARIDIMOU, Soma BANERJEE, Shadi YAGHI, James E SIEGLER, Petra ŠEDOVÁ, Joseph KWAN, de Sousa Diana AGUIAR, Jelle DEMEESTERE, Violiza INOA, Setareh Salehi OMRAN, Liqun ZHANG, Patrik MICHEL, Davide STRAMBO, Joao Pedro MARTO and Raul G NOGUEIRA. Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality. JOURNAL OF STROKE. SEOUL: KOREAN STROKE SOC, 2022, vol. 24, No 2, p. 256-265. ISSN 2287-6391. Available from: https://dx.doi.org/10.5853/jos.2022.00752.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality
Authors NGUYEN, Thanh N (guarantor), Muhammad M QURESHI, Piers KLEIN, Hiroshi YAMAGAMI, Mohamad ABDALKADER, Robert MIKULÍK (203 Czech Republic, belonging to the institution), Anvitha SATHYA, Ossama Yassin MANSOUR, Anna CZLONKOWSKA, Hannah LO, Thalia S FIELD, Andreas CHARIDIMOU, Soma BANERJEE, Shadi YAGHI, James E SIEGLER, Petra ŠEDOVÁ (203 Czech Republic), Joseph KWAN, de Sousa Diana AGUIAR, Jelle DEMEESTERE, Violiza INOA, Setareh Salehi OMRAN, Liqun ZHANG, Patrik MICHEL, Davide STRAMBO, Joao Pedro MARTO and Raul G NOGUEIRA.
Edition JOURNAL OF STROKE, SEOUL, KOREAN STROKE SOC, 2022, 2287-6391.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30230 Other clinical medicine subjects
Country of publisher Republic of Korea
Confidentiality degree is not subject to a state or trade secret
WWW STROKE
Impact factor Impact factor: 8.200
RIV identification code RIV/00216224:14110/22:00127760
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.5853/jos.2022.00752
UT WoS 000812327500008
Keywords (in Czech) COVID-19; Cerebral venous thrombosis; Vaccine-induced immune thrombotic thrombocytopenia; Mortality; SARS-CoV-2; Stroke
Keywords in English COVID-19; Cerebral venous thrombosis; Vaccine-induced immune thrombotic thrombocytopenia; Mortality; SARS-CoV-2; Stroke
Tags 14110127, Excelence Science, FNUSA, MU, RIV, rivok, Stroke, user, článek v časopise
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 5/4/2023 14:01.
Abstract
Since the first case in December 2019, coronavirus disease 2019 (COVID-19) has been responsible for more than 340 million infections and over 5.5 million deaths.1 Though most of the morbidity and mortality associated with COVID-19 is related to pulmonary complications, the disease has had wide-ranging systemic effects, including a range of neurological manifestations2,3 and disruption of coagulation homeostasis.4-7 This disruption in normal coagulation may trigger abnormal clotting events such as venous thromboembolism and stroke.8-10 Cerebral venous thrombosis (CVT) is a rare cause of stroke caused by the formation of clots in the brain’s venous system. The incidence of CVT has been reported to increase over the last decade, either from changing risk factors or improved detection.11-13 Compared to other forms of stroke, the incidence of CVT is more common in younger patients and women. CVT generally has a favorable prognosis with a good 90-day neurological outcome seen in greater than 80% of patients.
Links
90128, large research infrastructuresName: CZECRIN III
PrintDisplayed: 25/4/2024 09:48